PharmaMar announces new advances in oncology at ASCO 2015 for compounds YONDELIS® and PM1183
(Pharmamar) PharmaMar announces new advances in oncology at ASCO 2015 for its compounds YONDELIS® and PM1183 highlighting data in small cell lung cancer, soft tissue sarcoma, and mesothelioma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Lung Cancer | Mesothelioma | Sarcomas | Soft Tissue Sarcoma